sayeh lavasani, md, ms | neratinib and dose escalation | optimizing therapy for her2 disease
Published 3 years ago • 89 plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
6:46
yifan tu, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
8:47
sramila aithal, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
9:48
francis arena, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
1:03:44
new & supporting data for optimizing therapy in her2 breast cancer | dr. meisel & dr. soliman
-
3:11
neratinib prophylaxis in her2 metastatic breast cancer
-
0:25
copy of dr. shao on managing toxicity with neratinib in her2 breast cancer
-
4:09
her2 breast cancer: neratinib patient selection
-
33:37
hrt (hormone replacement therapy) treatment of menopause in 2024
-
33:34
sharing my her2 breast cancer diagnosis story at 35 years old
-
3:45
lutein for retinal detachment protection
-
1:53
optimal timing for neratinib
-
3:15
neratinib for metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
0:20
arsham sheybani, md talks about how the resure® sealant benefits premium cataract cases?
-
0:59
dr. varella on the results of monaleesa-7 in hr /her2- breast cancer
-
1:38
dr. shao on managing toxicity with neratinib in her2 breast cancer
-
4:07
new advances in hormonal therapies for er-positive breast cancer
-
22:35
ahd breast health s reiger
-
1:19
dr. slamon on os results of the monaleesa-3 trial in hr /her2- breast cancer
-
2:00
dr. hurvitz on neomonarch trial for hr breast cancer
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer